As corporate giants continue to reassess their portfolios amid economic shifts, strategic divestitures are becoming a common tool for companies looking to streamline operations and optimize financial health. JPMorgan analyst Arun Jayaram weighed in on reports that Occidental Petroleum Corp. (NYSE:OXY) is in discussions to sell its OxyChem division to its largest shareholder, Berkshire Hathaway Inc. (NYSE:BRK) (NYSE:BRK), in a deal worth about $10 billion.
The Wall Street Journal first reported the potential transaction, which would involve OxyChem’s 23 chemical plants and its key chlorovinyls business.
